Corvus hawaiiensis isolate bCorHaw1 chromosome 20, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036365.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PICALM interacting mitotic regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
PICALM interacting mitotic regulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PICALM interacting mitotic regulator, transcript variant X1
PITPNM family member 3, transcript variant X1
PITPNM family member 3, transcript variant X2
PITPNM family member 3, transcript variant X3
PITPNM family member 3, transcript variant X4
PITPNM family member 3, transcript variant X5
PITPNM family member 3, transcript variant X6
membrane-associated phosphatidylinositol transfer protein 3 isoform X1
membrane-associated phosphatidylinositol transfer protein 3 isoform X2
membrane-associated phosphatidylinositol transfer protein 3 isoform X3
membrane-associated phosphatidylinositol transfer protein 3 isoform X4
membrane-associated phosphatidylinositol transfer protein 3 isoform X5
KIAA0753 ortholog, transcript variant X1
KIAA0753 ortholog, transcript variant X3
KIAA0753 ortholog, transcript variant X4
KIAA0753 ortholog, transcript variant X7
KIAA0753 ortholog, transcript variant X5
KIAA0753 ortholog, transcript variant X6
KIAA0753 ortholog, transcript variant X2
KIAA0753 ortholog, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
KIAA0753 ortholog, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
KIAA0753 ortholog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
thioredoxin domain-containing protein 17
mediator of RNA polymerase II transcription subunit 31
solute carrier family 13 member 5, transcript variant X2
solute carrier family 13 member 5, transcript variant X3
solute carrier family 13 member 5, transcript variant X4
solute carrier family 13 member 5, transcript variant X1
solute carrier family 13 member 5 isoform X2
solute carrier family 13 member 5 isoform X1
solute carrier family 13 member 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
WSC domain containing 1, transcript variant X5
WSC domain containing 1, transcript variant X2
WSC domain containing 1, transcript variant X1
WSC domain containing 1, transcript variant X4
WSC domain containing 1, transcript variant X3
WSC domain-containing protein 1 isoform X2
WSC domain-containing protein 1 isoform X3
WSC domain-containing protein 1 isoform X1
RAP1 GTPase activating protein 2, transcript variant X6
RAP1 GTPase activating protein 2, transcript variant X3
RAP1 GTPase activating protein 2, transcript variant X4
RAP1 GTPase activating protein 2, transcript variant X1
RAP1 GTPase activating protein 2, transcript variant X2
RAP1 GTPase activating protein 2, transcript variant X7
RAP1 GTPase activating protein 2, transcript variant X8
RAP1 GTPase activating protein 2, transcript variant X5
rap1 GTPase-activating protein 2 isoform X3
rap1 GTPase-activating protein 2 isoform X4
rap1 GTPase-activating protein 2 isoform X2
rap1 GTPase-activating protein 2 isoform X1
rap1 GTPase-activating protein 2 isoform X6
rap1 GTPase-activating protein 2 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
clustered mitochondria homolog, transcript variant X2
clustered mitochondria protein homolog isoform X2
clustered mitochondria homolog, transcript variant X3
clustered mitochondria protein homolog isoform X3
clustered mitochondria homolog, transcript variant X1
clustered mitochondria protein homolog isoform X1
platelet activating factor acetylhydrolase 1b regulatory subunit 1, transcript variant X1
platelet activating factor acetylhydrolase 1b regulatory subunit 1, transcript variant X2
platelet-activating factor acetylhydrolase IB subunit beta
small G protein signaling modulator 2, transcript variant X4
small G protein signaling modulator 2, transcript variant X7
small G protein signaling modulator 2, transcript variant X2
small G protein signaling modulator 2, transcript variant X6
small G protein signaling modulator 2, transcript variant X3
small G protein signaling modulator 2, transcript variant X5
small G protein signaling modulator 2, transcript variant X1
small G protein signaling modulator 2 isoform X7
small G protein signaling modulator 2 isoform X2
small G protein signaling modulator 2 isoform X6
small G protein signaling modulator 2 isoform X3
small G protein signaling modulator 2 isoform X4
small G protein signaling modulator 2 isoform X5
small G protein signaling modulator 2 isoform X1
TNF alpha induced protein 1, transcript variant X2
TNF alpha induced protein 1, transcript variant X3
TNF alpha induced protein 1, transcript variant X1
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 isoform X2
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 isoform X1
intraflagellar transport 20, transcript variant X1
intraflagellar transport 20, transcript variant X2
intraflagellar transport protein 20 homolog isoform X1
intraflagellar transport protein 20 homolog isoform X2
serine/threonine-protein kinase NLK isoform X1
serine/threonine-protein kinase NLK isoform X2
LYR motif containing 9, transcript variant X3
LYR motif containing 9, transcript variant X5
LYR motif containing 9, transcript variant X6
LYR motif containing 9, transcript variant X2
LYR motif-containing protein 9 isoform X2
LYR motif containing 9, transcript variant X4
LYR motif containing 9, transcript variant X1
LYR motif-containing protein 9 isoform X1
LYR motif-containing protein 9 isoform X3
nitric oxide synthase 2, transcript variant X2
nitric oxide synthase 2, transcript variant X1
kinase suppressor of ras 1, transcript variant X2
kinase suppressor of ras 1, transcript variant X1
kinase suppressor of ras 1, transcript variant X4
kinase suppressor of ras 1, transcript variant X3
kinase suppressor of ras 1, transcript variant X5
WD repeat and SOCS box-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ecotropic viral integration site 2A, transcript variant X2
ecotropic viral integration site 2A, transcript variant X1
A-kinase anchoring protein 1, transcript variant X1
A-kinase anchoring protein 1, transcript variant X2
A-kinase anchoring protein 1, transcript variant X3
A-kinase anchor protein 1, mitochondrial
musashi RNA binding protein 2, transcript variant X1
musashi RNA binding protein 2, transcript variant X2
musashi RNA binding protein 2, transcript variant X6
musashi RNA binding protein 2, transcript variant X4
musashi RNA binding protein 2, transcript variant X9
musashi RNA binding protein 2, transcript variant X3
musashi RNA binding protein 2, transcript variant X7
musashi RNA binding protein 2, transcript variant X11
musashi RNA binding protein 2, transcript variant X12
musashi RNA binding protein 2, transcript variant X5
musashi RNA binding protein 2, transcript variant X8
musashi RNA binding protein 2, transcript variant X10
musashi RNA binding protein 2, transcript variant X13
musashi RNA binding protein 2, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
musashi RNA binding protein 2, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2 isoform X2
RNA-binding protein Musashi homolog 2 isoform X1
RNA-binding protein Musashi homolog 2 isoform X6
RNA-binding protein Musashi homolog 2 isoform X4
RNA-binding protein Musashi homolog 2 isoform X9
RNA-binding protein Musashi homolog 2 isoform X3
RNA-binding protein Musashi homolog 2 isoform X7
RNA-binding protein Musashi homolog 2 isoform X11
RNA-binding protein Musashi homolog 2 isoform X12
RNA-binding protein Musashi homolog 2 isoform X5
RNA-binding protein Musashi homolog 2 isoform X8
RNA-binding protein Musashi homolog 2 isoform X10
RNA-binding protein Musashi homolog 2 isoform X13
RNA-binding protein Musashi homolog 2 isoform X15
RNA-binding protein Musashi homolog 2 isoform X16
musashi RNA binding protein 2, transcript variant X14
RNA-binding protein Musashi homolog 2 isoform X14
28S ribosomal protein S23, mitochondrial
CUE domain containing 1, transcript variant X2
CUE domain containing 1, transcript variant X1
vascular endothelial zinc finger 1, transcript variant X3
vascular endothelial zinc finger 1, transcript variant X1
vascular endothelial zinc finger 1, transcript variant X2
vascular endothelial zinc finger 1 isoform X3
vascular endothelial zinc finger 1 isoform X1
vascular endothelial zinc finger 1 isoform X2
serine and arginine rich splicing factor 1
dynein light chain LC8-type 2, transcript variant X2
dynein light chain LC8-type 2, transcript variant X1
dynein light chain 2, cytoplasmic isoform X1
dynein light chain 2, cytoplasmic isoform X2
hepatocyte nuclear factor 1-beta isoform X1
hepatocyte nuclear factor 1-beta isoform X2
hepatocyte nuclear factor 1-beta isoform X3
hepatocyte nuclear factor 1-beta isoform X4
DExD-box helicase 52, transcript variant X1
DExD-box helicase 52, transcript variant X2
probable ATP-dependent RNA helicase DDX52 isoform X1
probable ATP-dependent RNA helicase DDX52 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transcriptional adaptor 2A, transcript variant X2
transcriptional adaptor 2A, transcript variant X1
transcriptional adaptor 2A, transcript variant X3
transcriptional adapter 2-alpha isoform X2
transcriptional adapter 2-alpha isoform X1
acetyl-CoA carboxylase alpha, transcript variant X7
acetyl-CoA carboxylase alpha, transcript variant X8
acetyl-CoA carboxylase alpha, transcript variant X5
acetyl-CoA carboxylase alpha, transcript variant X2
acetyl-CoA carboxylase alpha, transcript variant X1
acetyl-CoA carboxylase alpha, transcript variant X3
acetyl-CoA carboxylase alpha, transcript variant X4
acetyl-CoA carboxylase alpha, transcript variant X6
uncharacterized LOC125336327, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125336327, transcript variant X2
apoptosis antagonizing transcription factor
dehydrogenase/reductase SDR family member 11
gametogenetin binding protein 2, transcript variant X3
gametogenetin binding protein 2, transcript variant X1
gametogenetin binding protein 2, transcript variant X2
gametogenetin-binding protein 2 isoform X2
gametogenetin-binding protein 2 isoform X1
gametogenetin-binding protein 2 isoform X3
phosphatidylinositol glycan anchor biosynthesis class W, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class W, transcript variant X1
phosphatidylinositol-glycan biosynthesis class W protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger HIT domain-containing protein 3
lysophosphatidic acid receptor 1-like, transcript variant X2
lysophosphatidic acid receptor 1-like, transcript variant X1
ubiquitin specific peptidase 32, transcript variant X5
ubiquitin specific peptidase 32, transcript variant X2
ubiquitin specific peptidase 32, transcript variant X3
ubiquitin specific peptidase 32, transcript variant X1
ubiquitin specific peptidase 32, transcript variant X4
ubiquitin specific peptidase 32, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 32 isoform X5
ubiquitin carboxyl-terminal hydrolase 32 isoform X4
ubiquitin carboxyl-terminal hydrolase 32 isoform X2
ubiquitin carboxyl-terminal hydrolase 32 isoform X3
ubiquitin carboxyl-terminal hydrolase 32 isoform X1
ubiquitin carboxyl-terminal hydrolase 32 isoform X6
amyloid beta precursor protein binding protein 2
protein phosphatase, Mg2+/Mn2+ dependent 1D
BCAS3 microtubule associated cell migration factor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: BCAS3 microtubule associated cell migration factor
uncharacterized LOC125336266, transcript variant X2
uncharacterized LOC125336266, transcript variant X1
T-box transcription factor 4, transcript variant X2
T-box transcription factor 4, transcript variant X1
T-box transcription factor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BRCA1 interacting helicase 1, transcript variant X2
BRCA1 interacting helicase 1, transcript variant X1
Fanconi anemia group J protein isoform X2
Fanconi anemia group J protein isoform X1
mediator of RNA polymerase II transcription subunit 13
uncharacterized LOC125336129, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125336129, transcript variant X10
uncharacterized LOC125336129, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC125336129, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125336129, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC125336129, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125336129, transcript variant X1
uncharacterized LOC125336129, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125336129, transcript variant X8
uncharacterized LOC125336129, transcript variant X5
uncharacterized LOC125336129, transcript variant X2
uncharacterized LOC125336129, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger protein, transmembrane 1, transcript variant X1
E3 ubiquitin-protein ligase RNFT1 isoform X1
ring finger protein, transmembrane 1, transcript variant X2
E3 ubiquitin-protein ligase RNFT1 isoform X2
ribosomal protein S6 kinase B1, transcript variant X1
ribosomal protein S6 kinase beta-1 isoform X1
ribosomal protein S6 kinase B1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
ribosomal protein S6 kinase beta-1 isoform X2
ribosomal protein S6 kinase B1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vacuole membrane protein 1, transcript variant X1
vacuole membrane protein 1, transcript variant X2
vacuole membrane protein 1, transcript variant X3
vacuole membrane protein 1, transcript variant X4
vacuole membrane protein 1, transcript variant X5
peptidyl-tRNA hydrolase 2, mitochondrial
clathrin heavy chain, transcript variant X4
clathrin heavy chain, transcript variant X2
clathrin heavy chain, transcript variant X3
clathrin heavy chain, transcript variant X5
clathrin heavy chain, transcript variant X1
clathrin heavy chain, transcript variant X7
clathrin heavy chain, transcript variant X6
DEAH-box helicase 40, transcript variant X2
DEAH-box helicase 40, transcript variant X1
probable ATP-dependent RNA helicase DHX40 isoform X2
probable ATP-dependent RNA helicase DHX40 isoform X1
glycerophosphodiester phosphodiesterase domain containing 1
SMG8 nonsense mediated mRNA decay factor
nonsense-mediated mRNA decay factor SMG8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
spindle and kinetochore associated complex subunit 2
spindle and kinetochore-associated protein 2
protein phosphatase, Mg2+/Mn2+ dependent 1E, transcript variant X1
protein phosphatase, Mg2+/Mn2+ dependent 1E, transcript variant X2
uncharacterized LOC125336224, transcript variant X2
uncharacterized LOC125336224, transcript variant X1
testis expressed 14, intercellular bridge forming factor, transcript variant X1
testis expressed 14, intercellular bridge forming factor, transcript variant X2
inactive serine/threonine-protein kinase TEX14 isoform X1
inactive serine/threonine-protein kinase TEX14 isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
testis expressed 14, intercellular bridge forming factor, transcript variant X3
testis expressed 14, intercellular bridge forming factor, transcript variant X4
inactive serine/threonine-protein kinase TEX14 isoform X3
inactive serine/threonine-protein kinase TEX14 isoform X4
testis expressed 14, intercellular bridge forming factor, transcript variant X5
inactive serine/threonine-protein kinase TEX14 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
double C2 domain beta, transcript variant X2
double C2 domain beta, transcript variant X1
double C2-like domain-containing protein beta isoform X2
double C2-like domain-containing protein beta isoform X1
rabphilin 3A like (without C2 domains), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
rabphilin 3A like (without C2 domains), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rabphilin 3A like (without C2 domains), transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rabphilin 3A like (without C2 domains), transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rabphilin 3A like (without C2 domains), transcript variant X5
rabphilin 3A like (without C2 domains), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
rabphilin 3A like (without C2 domains), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
VPS53 subunit of GARP complex, transcript variant X2
VPS53 subunit of GARP complex, transcript variant X1
VPS53 subunit of GARP complex, transcript variant X3
vacuolar protein sorting-associated protein 53 homolog isoform X2
vacuolar protein sorting-associated protein 53 homolog isoform X1
vacuolar protein sorting-associated protein 53 homolog isoform X3
gem nuclear organelle associated protein 4
glyoxalase domain containing 4, transcript variant X1
glyoxalase domain containing 4, transcript variant X2
glyoxalase domain-containing protein 4 isoform X1
glyoxalase domain-containing protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
multidrug and toxin extrusion protein 2-like, transcript variant X2
multidrug and toxin extrusion protein 2-like, transcript variant X1
multidrug and toxin extrusion protein 2-like, transcript variant X3
multidrug and toxin extrusion protein 2-like, transcript variant X4
multidrug and toxin extrusion protein 2-like isoform X1
multidrug and toxin extrusion protein 1-like isoform X3
multidrug and toxin extrusion protein 2-like isoform X2
aldehyde dehydrogenase family 3 member A2-like, transcript variant X1
aldehyde dehydrogenase family 3 member A2-like, transcript variant X2
aldehyde dehydrogenase family 3 member A2-like
aldehyde dehydrogenase family 3 member A2-like, transcript variant X3
aldehyde dehydrogenase family 3 member A2-like, transcript variant X6
aldehyde dehydrogenase family 3 member A2-like, transcript variant X4
aldehyde dehydrogenase family 3 member A2-like, transcript variant X8
aldehyde dehydrogenase family 3 member A2-like, transcript variant X7
aldehyde dehydrogenase family 3 member A2-like, transcript variant X5
aldehyde dehydrogenase family 3 member A2-like isoform X3
aldehyde dehydrogenase family 3 member A2-like isoform X2
aldehyde dehydrogenase family 3 member A2-like isoform X1
unc-51 like autophagy activating kinase 2, transcript variant X2
unc-51 like autophagy activating kinase 2, transcript variant X1
serine/threonine-protein kinase ULK2 isoform X2
serine/threonine-protein kinase ULK2 isoform X1
A-kinase anchoring protein 10, transcript variant X1
A-kinase anchoring protein 10, transcript variant X3
A-kinase anchoring protein 10, transcript variant X2
A-kinase anchor protein 10, mitochondrial isoform X1
A-kinase anchor protein 10, mitochondrial isoform X2
uncharacterized LOC125336206, transcript variant X2
uncharacterized LOC125336206, transcript variant X1
transient receptor potential cation channel subfamily V member 3, transcript variant X2
transient receptor potential cation channel subfamily V member 3, transcript variant X3
transient receptor potential cation channel subfamily V member 3, transcript variant X1
transient receptor potential cation channel subfamily V member 3 isoform X3
transient receptor potential cation channel subfamily V member 3 isoform X2
transient receptor potential cation channel subfamily V member 3 isoform X1
transient receptor potential cation channel subfamily V member 1, transcript variant X2
transient receptor potential cation channel subfamily V member 1, transcript variant X1
transient receptor potential cation channel subfamily V member 1 isoform X1
transient receptor potential cation channel subfamily V member 1 isoform X2
sedoheptulokinase, transcript variant X2
sedoheptulokinase, transcript variant X1
cystinosin, lysosomal cystine transporter, transcript variant X1
cystinosin, lysosomal cystine transporter, transcript variant X3
cystinosin, lysosomal cystine transporter, transcript variant X2
cystinosin, lysosomal cystine transporter, transcript variant X4
Tax1 binding protein 3, transcript variant X2
Tax1 binding protein 3, transcript variant X1
purinergic receptor P2X 5, transcript variant X1
purinergic receptor P2X 5, transcript variant X2
transient receptor potential cation channel subfamily V member 2-like, transcript variant X1
transient receptor potential cation channel subfamily V member 2-like isoform X1
transient receptor potential cation channel subfamily V member 2-like, transcript variant X2
transient receptor potential cation channel subfamily V member 2-like isoform X2
uncharacterized LOC125336294, transcript variant X1
uncharacterized LOC125336294, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class L, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class L, transcript variant X3
phosphatidylinositol glycan anchor biosynthesis class L, transcript variant X1
N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase isoform X2
N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase isoform X3
N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase isoform X1
nuclear receptor corepressor 1, transcript variant X2
nuclear receptor corepressor 1, transcript variant X1
tetratricopeptide repeat protein 19, mitochondrial
zinc finger SWIM-type containing 7, transcript variant X2
zinc finger SWIM-type containing 7, transcript variant X1
zinc finger SWIM-type containing 7, transcript variant X3
zinc finger SWIM domain-containing protein 7
sperm antigen with calponin homology and coiled-coil domains 1, transcript variant X3
sperm antigen with calponin homology and coiled-coil domains 1, transcript variant X2
sperm antigen with calponin homology and coiled-coil domains 1, transcript variant X1
sperm antigen with calponin homology and coiled-coil domains 1, transcript variant X4
sperm antigen with calponin homology and coiled-coil domains 1, transcript variant X5
sperm antigen with calponin homology and coiled-coil domains 1, transcript variant X6
translocase of inner mitochondrial membrane 22
mitochondrial import inner membrane translocase subunit Tim22
ABR activator of RhoGEF and GTPase, transcript variant X1
ABR activator of RhoGEF and GTPase, transcript variant X2
ABR activator of RhoGEF and GTPase, transcript variant X3
ABR activator of RhoGEF and GTPase, transcript variant X4
active breakpoint cluster region-related protein isoform X2
active breakpoint cluster region-related protein isoform X1
active breakpoint cluster region-related protein isoform X3
active breakpoint cluster region-related protein isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
class A basic helix-loop-helix protein 9
trafficking regulator of GLUT4 (SLC2A4) 1
golgi SNAP receptor complex member 1, transcript variant X2
golgi SNAP receptor complex member 1, transcript variant X1
Golgi SNAP receptor complex member 1 isoform X2
Golgi SNAP receptor complex member 1 isoform X1
transmembrane and immunoglobulin domain containing 1, transcript variant X4
transmembrane and immunoglobulin domain containing 1, transcript variant X1
transmembrane and immunoglobulin domain containing 1, transcript variant X2
transmembrane and immunoglobulin domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane and immunoglobulin domain-containing protein 1 isoform X2
transmembrane and immunoglobulin domain-containing protein 1 isoform X1
transmembrane and immunoglobulin domain-containing protein 1 isoform X3
transmembrane and immunoglobulin domain-containing protein 1 isoform X4
solute carrier family 6 member 4, transcript variant X2
solute carrier family 6 member 4, transcript variant X1
nuclear speckle splicing regulatory protein 1
EF-hand calcium-binding domain-containing protein 5
slingshot protein phosphatase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
protein phosphatase Slingshot homolog 2 isoform X1
slingshot protein phosphatase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein phosphatase Slingshot homolog 2 isoform X3
slingshot protein phosphatase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
protein phosphatase Slingshot homolog 2 isoform X2
ankyrin repeat domain 13B, transcript variant X1
ankyrin repeat domain 13B, transcript variant X2
ankyrin repeat domain-containing protein 13B isoform X2
ankyrin repeat domain-containing protein 13B isoform X1
ARF GTPase-activating protein GIT1 isoform X1
ARF GTPase-activating protein GIT1 isoform X3
ARF GTPase-activating protein GIT1 isoform X2
ARF GTPase-activating protein GIT1 isoform X4
serine/threonine-protein kinase TAO1 isoform X2
serine/threonine-protein kinase TAO1 isoform X1
uncharacterized LOC125336134, transcript variant X1
uncharacterized LOC125336134, transcript variant X2
nuclear FMR1 interacting protein 2, transcript variant X1
nuclear FMR1 interacting protein 2, transcript variant X2
nuclear fragile X mental retardation-interacting protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
unconventional myosin-XVIIIa isoform X22
unconventional myosin-XVIIIa isoform X10
unconventional myosin-XVIIIa isoform X11
unconventional myosin-XVIIIa isoform X12
unconventional myosin-XVIIIa isoform X13
unconventional myosin-XVIIIa isoform X14
unconventional myosin-XVIIIa isoform X15
unconventional myosin-XVIIIa isoform X16
unconventional myosin-XVIIIa isoform X18
unconventional myosin-XVIIIa isoform X21
unconventional myosin-XVIIIa isoform X19
unconventional myosin-XVIIIa isoform X20
unconventional myosin-XVIIIa isoform X23
unconventional myosin-XVIIIa isoform X17
unconventional myosin-XVIIIa isoform X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
seizure related 6 homolog, transcript variant X1
seizure related 6 homolog, transcript variant X2
Era like 12S mitochondrial rRNA chaperone 1, transcript variant X1
Era like 12S mitochondrial rRNA chaperone 1, transcript variant X2
family with sequence similarity 222 member B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
family with sequence similarity 222 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
family with sequence similarity 222 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
family with sequence similarity 222 member B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NIMA related kinase 8, transcript variant X3
NIMA related kinase 8, transcript variant X1
serine/threonine-protein kinase Nek8 isoform X1
serine/threonine-protein kinase Nek8 isoform X3
NIMA related kinase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase Nek8 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00150
COORDINATES: nucleotide motif:Rfam:12.0:RF00266
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
adenine phosphoribosyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
adenine phosphoribosyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
adenine phosphoribosyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
adenine phosphoribosyltransferase-like isoform X2
adenine phosphoribosyltransferase-like isoform X3
adenine phosphoribosyltransferase-like isoform X1
SPT6 homolog, histone chaperone and transcription elongation factor, transcript variant X2
SPT6 homolog, histone chaperone and transcription elongation factor, transcript variant X1
SPT6 homolog, histone chaperone and transcription elongation factor, transcript variant X3
KIAA0100 ortholog, transcript variant X1
KIAA0100 ortholog, transcript variant X2
LOW QUALITY PROTEIN: ribosomal protein S6 kinase-related protein
leucine-rich repeat extensin-like protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
sperm associated antigen 5, transcript variant X1
sperm associated antigen 5, transcript variant X3
sperm associated antigen 5, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class S
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sterile alpha and TIR motif containing 1, transcript variant X2
sterile alpha and TIR motif containing 1, transcript variant X1
LOW QUALITY PROTEIN: kinesin-like protein KIF12
DNA polymerase delta interacting protein 2
TSR1 ribosome maturation factor, transcript variant X1
TSR1 ribosome maturation factor, transcript variant X2
pre-rRNA-processing protein TSR1 homolog isoform X1
pre-rRNA-processing protein TSR1 homolog isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00580
SMG6 nonsense mediated mRNA decay factor, transcript variant X1
telomerase-binding protein EST1A isoform X1
SMG6 nonsense mediated mRNA decay factor, transcript variant X2
SMG6 nonsense mediated mRNA decay factor, transcript variant X3
telomerase-binding protein EST1A isoform X2
telomerase-binding protein EST1A isoform X3
HIC ZBTB transcriptional repressor 1, transcript variant X2
HIC ZBTB transcriptional repressor 1, transcript variant X1
HIC ZBTB transcriptional repressor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
OVCA2 serine hydrolase domain containing
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1
replication protein A 70 kDa DNA-binding subunit
SET and MYND domain containing 4, transcript variant X2
SET and MYND domain containing 4, transcript variant X1
SET and MYND domain-containing protein 4 isoform X1
SET and MYND domain-containing protein 4 isoform X2
serpin family F member 2, transcript variant X1
serpin family F member 2, transcript variant X2
WD repeat domain 81, transcript variant X1
WD repeat domain 81, transcript variant X2
apoptosis-inducing factor 3-like, transcript variant X5
apoptosis-inducing factor 3-like, transcript variant X3
apoptosis-inducing factor 3-like isoform X4
apoptosis-inducing factor 3-like isoform X2
apoptosis-inducing factor 3-like, transcript variant X4
apoptosis-inducing factor 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
apoptosis-inducing factor 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
apoptosis-inducing factor 3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
apoptosis-inducing factor 3-like isoform X3
apoptosis-inducing factor 3-like isoform X1
apoptosis-inducing factor 3-like isoform X5
apoptosis-inducing factor 3-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
apoptosis-inducing factor 3-like isoform X6
solute carrier family 43 member 2, transcript variant X2
solute carrier family 43 member 2, transcript variant X1
large neutral amino acids transporter small subunit 4 isoform X1
solute carrier family 43 member 2, transcript variant X3
large neutral amino acids transporter small subunit 4 isoform X2
phosphatidylinositol transfer protein alpha
phosphatidylinositol transfer protein alpha isoform
inositol polyphosphate-5-phosphatase K, transcript variant X3
inositol polyphosphate 5-phosphatase K isoform X3
inositol polyphosphate-5-phosphatase K, transcript variant X1
inositol polyphosphate-5-phosphatase K, transcript variant X2
inositol polyphosphate 5-phosphatase K isoform X1
inositol polyphosphate 5-phosphatase K isoform X2
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon
CRK proto-oncogene, adaptor protein, transcript variant X1
CRK proto-oncogene, adaptor protein, transcript variant X6
CRK proto-oncogene, adaptor protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
CRK proto-oncogene, adaptor protein, transcript variant X3
CRK proto-oncogene, adaptor protein, transcript variant X4
CRK proto-oncogene, adaptor protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
uncharacterized LOC125336171, transcript variant X9
uncharacterized LOC125336171, transcript variant X7
uncharacterized LOC125336171, transcript variant X2
uncharacterized LOC125336171, transcript variant X8
uncharacterized LOC125336171, transcript variant X10
uncharacterized LOC125336171, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC125336171, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125336171, transcript variant X6
uncharacterized LOC125336171, transcript variant X5
uncharacterized LOC125336171, transcript variant X1
uncharacterized LOC125336171, transcript variant X4
uncharacterized LOC125336171, transcript variant X12
COORDINATES: nucleotide motif:Rfam:12.0:RF00277
COORDINATES: nucleotide motif:Rfam:12.0:RF00571
leucine-rich repeat-containing protein 75A
transmembrane protein 248, transcript variant X1
transmembrane protein 248, transcript variant X2
RAB guanine nucleotide exchange factor 1, transcript variant X6
RAB guanine nucleotide exchange factor 1, transcript variant X7
RAB guanine nucleotide exchange factor 1, transcript variant X5
RAB guanine nucleotide exchange factor 1, transcript variant X4
RAB guanine nucleotide exchange factor 1, transcript variant X3
RAB guanine nucleotide exchange factor 1, transcript variant X2
RAB guanine nucleotide exchange factor 1, transcript variant X1
potassium channel tetramerization domain containing 7
tyrosylprotein sulfotransferase 1, transcript variant X3
tyrosylprotein sulfotransferase 1, transcript variant X2
tyrosylprotein sulfotransferase 1, transcript variant X4
tyrosylprotein sulfotransferase 1, transcript variant X1
tyrosylprotein sulfotransferase 1, transcript variant X6
tyrosylprotein sulfotransferase 1, transcript variant X5
DNA-directed RNA polymerase III subunit RPC9
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glucuronidase beta, transcript variant X2
glucuronidase beta, transcript variant X1
vitamin K epoxide reductase complex subunit 1 like 1
vitamin K epoxide reductase complex subunit 1-like protein 1
coiled-coil-helix-coiled-coil-helix domain containing 2
coiled-coil-helix-coiled-coil-helix domain-containing protein 2
phosphorylase kinase catalytic subunit gamma 1, transcript variant X2
phosphorylase kinase catalytic subunit gamma 1, transcript variant X1
phosphorylase kinase catalytic subunit gamma 1, transcript variant X3
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform isoform X1
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform isoform X3
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform isoform X2
sulfatase modifying factor 2, transcript variant X2
sulfatase modifying factor 2, transcript variant X1
inactive C-alpha-formylglycine-generating enzyme 2 isoform X1
inactive C-alpha-formylglycine-generating enzyme 2 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00398
COORDINATES: nucleotide motif:Rfam:12.0:RF00414
mitochondrial ribosomal protein S17, transcript variant X1
mitochondrial ribosomal protein S17, transcript variant X3
mitochondrial ribosomal protein S17, transcript variant X2
28S ribosomal protein S17, mitochondrial
uncharacterized LOC125336452, transcript variant X4
uncharacterized protein LOC125336452 isoform X4
uncharacterized LOC125336452, transcript variant X1
uncharacterized protein LOC125336452 isoform X1
uncharacterized LOC125336452, transcript variant X2
uncharacterized protein LOC125336452 isoform X2
uncharacterized LOC125336452, transcript variant X3
uncharacterized LOC125336452, transcript variant X5
uncharacterized protein LOC125336452 isoform X3
ring finger and FYVE like domain containing E3 ubiquitin protein ligase, transcript variant X5
ring finger and FYVE like domain containing E3 ubiquitin protein ligase, transcript variant X1
ring finger and FYVE like domain containing E3 ubiquitin protein ligase, transcript variant X4
ring finger and FYVE like domain containing E3 ubiquitin protein ligase, transcript variant X3
ring finger and FYVE like domain containing E3 ubiquitin protein ligase, transcript variant X2
DNA repair protein RAD51 homolog 4 isoform X1
DNA repair protein RAD51 homolog 4 isoform X2
unc-45 myosin chaperone B, transcript variant X1
unc-45 myosin chaperone B, transcript variant X2
unc-45 myosin chaperone B, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00288
adaptor related protein complex 2 subunit beta 1, transcript variant X4
adaptor related protein complex 2 subunit beta 1, transcript variant X1
adaptor related protein complex 2 subunit beta 1, transcript variant X2
adaptor related protein complex 2 subunit beta 1, transcript variant X3
RAS like family 10 member B, transcript variant X3
RAS like family 10 member B, transcript variant X1
RAS like family 10 member B, transcript variant X2
ras-like protein family member 10B isoform X2
ras-like protein family member 10B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
matrix metallopeptidase 28, transcript variant X1
matrix metallopeptidase 28, transcript variant X2
matrix metallopeptidase 28, transcript variant X3
TATA-box binding protein associated factor 15
TATA-binding protein-associated factor 2N
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
NADPH--cytochrome P450 reductase, transcript variant X2
NADPH--cytochrome P450 reductase, transcript variant X1
NADPH--cytochrome P450 reductase, transcript variant X3
NADPH--cytochrome P450 reductase isoform X1
NADPH--cytochrome P450 reductase, transcript variant X4
NADPH--cytochrome P450 reductase isoform X2
serine/threonine/tyrosine interacting like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine/tyrosine-interacting-like protein 1 isoform X1
serine/threonine/tyrosine interacting like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
serine/threonine/tyrosine-interacting-like protein 1 isoform X2
serine/arginine repetitive matrix protein 3
heat shock protein family B (small) member 1
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma
scavenger receptor cysteine rich family member with 4 domains
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
scavenger receptor cysteine-rich domain-containing group B protein
deltex E3 ubiquitin ligase 2, transcript variant X1
deltex E3 ubiquitin ligase 2, transcript variant X4
deltex E3 ubiquitin ligase 2, transcript variant X2
deltex E3 ubiquitin ligase 2, transcript variant X3
probable E3 ubiquitin-protein ligase DTX2 isoform X1
probable E3 ubiquitin-protein ligase DTX2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uroplakin-3b-like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uroplakin-3b-like protein 1, transcript variant X1
DNA-directed RNA polymerase II subunit RPB11-a
leucine rich repeats and WD repeat domain containing 1, transcript variant X1
leucine rich repeats and WD repeat domain containing 1, transcript variant X2
leucine rich repeats and WD repeat domain containing 1, transcript variant X3
leucine rich repeats and WD repeat domain containing 1, transcript variant X4
leucine-rich repeat and WD repeat-containing protein 1 isoform X1
leucine-rich repeat and WD repeat-containing protein 1 isoform X2
alkB homolog 4, lysine demethylase, transcript variant X2
alkB homolog 4, lysine demethylase, transcript variant X4
alkB homolog 4, lysine demethylase, transcript variant X6
alkB homolog 4, lysine demethylase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
alkB homolog 4, lysine demethylase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alkB homolog 4, lysine demethylase, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 isoform X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 isoform X1
ORAI calcium release-activated calcium modulator 2
cut like homeobox 1, transcript variant X8
cut like homeobox 1, transcript variant X6
cut like homeobox 1, transcript variant X7
cut like homeobox 1, transcript variant X5
cut like homeobox 1, transcript variant X3
cut like homeobox 1, transcript variant X1
cut like homeobox 1, transcript variant X2
cut like homeobox 1, transcript variant X4
myosin light chain 10, transcript variant X1
myosin light chain 10, transcript variant X2
myosin regulatory light chain 10 isoform X1
myosin regulatory light chain 10 isoform X2
3 beta-hydroxysteroid dehydrogenase type 7-like
collagen type XXVI alpha 1 chain, transcript variant X7
collagen type XXVI alpha 1 chain, transcript variant X2
collagen type XXVI alpha 1 chain, transcript variant X5
collagen type XXVI alpha 1 chain, transcript variant X6
collagen type XXVI alpha 1 chain, transcript variant X4
collagen type XXVI alpha 1 chain, transcript variant X1
collagen type XXVI alpha 1 chain, transcript variant X3
intraflagellar transport protein 22 homolog
uncharacterized LOC125336127, transcript variant X2
uncharacterized LOC125336127, transcript variant X5
uncharacterized LOC125336127, transcript variant X3
uncharacterized LOC125336127, transcript variant X6
uncharacterized LOC125336127, transcript variant X4
uncharacterized LOC125336127, transcript variant X1
rabaptin, RAB GTPase binding effector protein 1
RPA interacting protein, transcript variant X1
RPA interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
complement component 1 Q subcomponent-binding protein, mitochondrial
LOW QUALITY PROTEIN: ATP-dependent RNA helicase DHX33
calcium/calmodulin dependent protein kinase kinase 1, transcript variant X3
calcium/calmodulin dependent protein kinase kinase 1, transcript variant X2
calcium/calmodulin dependent protein kinase kinase 1, transcript variant X4
calcium/calmodulin dependent protein kinase kinase 1, transcript variant X1
calcium/calmodulin-dependent protein kinase kinase 1 isoform X2
calcium/calmodulin-dependent protein kinase kinase 1 isoform X1
purinergic receptor P2X 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
purinergic receptor P2X 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
purinergic receptor P2X 1, transcript variant X1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3, transcript variant X2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3, transcript variant X1
sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform X1
sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform X2
zinc finger ZZ-type and EF-hand domain containing 1, transcript variant X2
zinc finger ZZ-type and EF-hand domain containing 1, transcript variant X1
zinc finger ZZ-type and EF-hand domain-containing protein 1 isoform X2
zinc finger ZZ-type and EF-hand domain-containing protein 1 isoform X1
ankyrin repeat and FYVE domain containing 1, transcript variant X3
ankyrin repeat and FYVE domain containing 1, transcript variant X1
ankyrin repeat and FYVE domain containing 1, transcript variant X2
ubiquitin conjugating enzyme E2 G1, transcript variant X2
ubiquitin conjugating enzyme E2 G1, transcript variant X1
ubiquitin conjugating enzyme E2 G1, transcript variant X3
ubiquitin-conjugating enzyme E2 G1 isoform X1
ubiquitin-conjugating enzyme E2 G1 isoform X2
protein spinster homolog 3-like, transcript variant X1
protein spinster homolog 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein spinster homolog 3-like isoform X1
protein spinster homolog 3-like isoform X2
protein spinster homolog 2-like, transcript variant X6
protein spinster homolog 2-like, transcript variant X2
protein spinster homolog 2-like, transcript variant X1
protein spinster homolog 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein spinster homolog 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein spinster homolog 2-like, transcript variant X4
protein spinster homolog 2-like isoform X2
protein spinster homolog 2-like isoform X3
protein spinster homolog 2-like isoform X1
eukaryotic translation initiation factor 4H, transcript variant X1
eukaryotic translation initiation factor 4H, transcript variant X2
eukaryotic translation initiation factor 4H isoform X1
eukaryotic translation initiation factor 4H isoform X2
linker for activation of T cells family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
linker for activation of T cells family member 2, transcript variant X2
linker for activation of T-cells family member 2 isoform X2
linker for activation of T-cells family member 2 isoform X1
replication factor C subunit 2, transcript variant X5
replication factor C subunit 2, transcript variant X1
replication factor C subunit 2, transcript variant X2
replication factor C subunit 2 isoform X4
replication factor C subunit 2 isoform X1
replication factor C subunit 2, transcript variant X4
replication factor C subunit 2 isoform X3
replication factor C subunit 2, transcript variant X3
replication factor C subunit 2 isoform X2
CAP-Gly domain containing linker protein 2, transcript variant X2
CAP-Gly domain containing linker protein 2, transcript variant X10
CAP-Gly domain containing linker protein 2, transcript variant X1
CAP-Gly domain containing linker protein 2, transcript variant X14
CAP-Gly domain containing linker protein 2, transcript variant X3
CAP-Gly domain containing linker protein 2, transcript variant X6
CAP-Gly domain containing linker protein 2, transcript variant X4
CAP-Gly domain containing linker protein 2, transcript variant X8
CAP-Gly domain containing linker protein 2, transcript variant X5
CAP-Gly domain containing linker protein 2, transcript variant X7
CAP-Gly domain containing linker protein 2, transcript variant X13
CAP-Gly domain containing linker protein 2, transcript variant X11
CAP-Gly domain containing linker protein 2, transcript variant X9
CAP-Gly domain containing linker protein 2, transcript variant X12
CAP-Gly domain-containing linker protein 2 isoform X1
CAP-Gly domain-containing linker protein 2 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase RBBP6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 9% coverage of the annotated genomic feature by RNAseq alignments
sperm acrosome membrane-associated protein 6
fibrinogen-like protein 1-like protein, transcript variant X1
fibrinogen-like protein 1-like protein, transcript variant X2
fibrinogen-like protein 1-like protein isoform X1
fibrinogen-like protein 1-like protein isoform X2
VPS37D subunit of ESCRT-I, transcript variant X3
vacuolar protein sorting-associated protein 37D isoform X3
VPS37D subunit of ESCRT-I, transcript variant X1
VPS37D subunit of ESCRT-I, transcript variant X2
VPS37D subunit of ESCRT-I, transcript variant X4
vacuolar protein sorting-associated protein 37D isoform X1
vacuolar protein sorting-associated protein 37D isoform X2
vacuolar protein sorting-associated protein 37D isoform X4
DnaJ heat shock protein family (Hsp40) member C30
dnaJ homolog subfamily C member 30, mitochondrial
BUD23 rRNA methyltransferase and ribosome maturation factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
BUD23 rRNA methyltransferase and ribosome maturation factor, transcript variant X1
BUD23 rRNA methyltransferase and ribosome maturation factor, transcript variant X3
probable 18S rRNA (guanine-N(7))-methyltransferase
MKS transition zone complex subunit 1, transcript variant X1
MKS transition zone complex subunit 1, transcript variant X4
MKS transition zone complex subunit 1, transcript variant X2
MKS transition zone complex subunit 1, transcript variant X3
Meckel syndrome type 1 protein isoform X1
Meckel syndrome type 1 protein isoform X4
Meckel syndrome type 1 protein isoform X2
Meckel syndrome type 1 protein isoform X3
GTF2I repeat domain containing 1, transcript variant X2
GTF2I repeat domain containing 1, transcript variant X1
GTF2I repeat domain containing 1, transcript variant X7
GTF2I repeat domain containing 1, transcript variant X4
GTF2I repeat domain containing 1, transcript variant X5
GTF2I repeat domain containing 1, transcript variant X8
GTF2I repeat domain containing 1, transcript variant X6
GTF2I repeat domain containing 1, transcript variant X3
GTF2I repeat domain containing 1, transcript variant X10
GTF2I repeat domain containing 1, transcript variant X9
general transcription factor II-I repeat domain-containing protein 1 isoform X1
general transcription factor II-I repeat domain-containing protein 1 isoform X7
general transcription factor II-I repeat domain-containing protein 1 isoform X4
general transcription factor II-I repeat domain-containing protein 1 isoform X5
general transcription factor II-I repeat domain-containing protein 1 isoform X8
general transcription factor II-I repeat domain-containing protein 1 isoform X6
general transcription factor II-I repeat domain-containing protein 1 isoform X3
general transcription factor II-I repeat domain-containing protein 1 isoform X9
general transcription factor II-I repeat domain-containing protein 1 isoform X10
general transcription factor II-I repeat domain-containing protein 1 isoform X2
general transcription factor IIi, transcript variant X4
general transcription factor IIi, transcript variant X19
general transcription factor IIi, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
general transcription factor IIi, transcript variant X14
general transcription factor IIi, transcript variant X12
general transcription factor IIi, transcript variant X16
general transcription factor IIi, transcript variant X9
general transcription factor IIi, transcript variant X7
general transcription factor IIi, transcript variant X11
general transcription factor IIi, transcript variant X8
general transcription factor IIi, transcript variant X15
general transcription factor IIi, transcript variant X17
general transcription factor IIi, transcript variant X6
general transcription factor IIi, transcript variant X13
general transcription factor IIi, transcript variant X5
general transcription factor IIi, transcript variant X20
general transcription factor IIi, transcript variant X1
general transcription factor IIi, transcript variant X10
general transcription factor IIi, transcript variant X3
general transcription factor IIi, transcript variant X2
general transcription factor II-I isoform X2
general transcription factor II-I isoform X5
general transcription factor II-I isoform X20
general transcription factor II-I isoform X1
general transcription factor II-I isoform X9
general transcription factor II-I isoform X7
general transcription factor II-I isoform X14
general transcription factor II-I isoform X11
general transcription factor II-I isoform X12
general transcription factor II-I isoform X16
general transcription factor II-I isoform X10
general transcription factor II-I isoform X8
general transcription factor II-I isoform X15
general transcription factor II-I isoform X17
general transcription factor II-I isoform X19
general transcription factor II-I isoform X6
general transcription factor II-I isoform X13
general transcription factor II-I isoform X3
general transcription factor II-I isoform X18
general transcription factor II-I isoform X4
neutrophil cytosolic factor 1, transcript variant X3
neutrophil cytosolic factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
neutrophil cytosolic factor 1, transcript variant X4
neutrophil cytosolic factor 1, transcript variant X2
RCC1-like G exchanging factor-like protein
cytosolic arginine sensor for mTORC1 subunit 2, transcript variant X1
cytosolic arginine sensor for mTORC1 subunit 2, transcript variant X2
cytosolic arginine sensor for mTORC1 subunit 2 isoform X1
cytosolic arginine sensor for mTORC1 subunit 2 isoform X2
uncharacterized LOC125336477, transcript variant X2
uncharacterized LOC125336477, transcript variant X1
activator of transcription and developmental regulator AUTS2, transcript variant X1
activator of transcription and developmental regulator AUTS2, transcript variant X2
autism susceptibility gene 2 protein isoform X1
autism susceptibility gene 2 protein isoform X2
polypeptide N-acetylgalactosaminyltransferase 17
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1-like, transcript variant X3
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1-like, transcript variant X1
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1-like, transcript variant X2
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1-like isoform X1
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1-like, transcript variant X4
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: coiled-coil domain-containing protein 183
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LIM domain kinase 1, transcript variant X1
LIM domain kinase 1, transcript variant X2
LIM domain kinase 1, transcript variant X3
LIM domain kinase 1, transcript variant X4
methyltransferase like 27, transcript variant X2
methyltransferase like 27, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
myotubularin related protein 4, transcript variant X2
myotubularin-related protein 4 isoform X2
myotubularin related protein 4, transcript variant X1
myotubularin-related protein 4 isoform X1
ring finger protein 43, transcript variant X1
ring finger protein 43, transcript variant X3
ring finger protein 43, transcript variant X4
ring finger protein 43, transcript variant X2
E3 ubiquitin-protein ligase RNF43 isoform X1
E3 ubiquitin-protein ligase RNF43 isoform X2
SPT4 homolog, DSIF elongation factor subunit
TSPO associated protein 1, transcript variant X1
TSPO associated protein 1, transcript variant X3
TSPO associated protein 1, transcript variant X4
TSPO associated protein 1, transcript variant X5
TSPO associated protein 1, transcript variant X6
TSPO associated protein 1, transcript variant X10
TSPO associated protein 1, transcript variant X9
TSPO associated protein 1, transcript variant X2
TSPO associated protein 1, transcript variant X7
TSPO associated protein 1, transcript variant X8
peripheral-type benzodiazepine receptor-associated protein 1 isoform X1
peripheral-type benzodiazepine receptor-associated protein 1 isoform X3
peripheral-type benzodiazepine receptor-associated protein 1 isoform X4
peripheral-type benzodiazepine receptor-associated protein 1 isoform X5
peripheral-type benzodiazepine receptor-associated protein 1 isoform X6
peripheral-type benzodiazepine receptor-associated protein 1 isoform X9
peripheral-type benzodiazepine receptor-associated protein 1 isoform X8
peripheral-type benzodiazepine receptor-associated protein 1 isoform X2
peripheral-type benzodiazepine receptor-associated protein 1 isoform X7
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha-like
LOW QUALITY PROTEIN: 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
huntingtin interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
huntingtin-interacting protein 1 isoform X2
huntingtin interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
huntingtin-interacting protein 1 isoform X1
huntingtin interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
huntingtin-interacting protein 1 isoform X3
nuclear envelope pore membrane protein POM 121C
28S rRNA (cytosine-C(5))-methyltransferase
FKBP prolyl isomerase family member 6 (inactive), transcript variant X1
FKBP prolyl isomerase family member 6 (inactive), transcript variant X2
inactive peptidyl-prolyl cis-trans isomerase FKBP6 isoform X1
inactive peptidyl-prolyl cis-trans isomerase FKBP6 isoform X2
bromodomain adjacent to zinc finger domain 1B
fibrinogen-like protein 1-like protein, transcript variant X4
fibrinogen-like protein 1-like protein, transcript variant X3
MLX interacting protein like, transcript variant X3
MLX interacting protein like, transcript variant X1
MLX interacting protein like, transcript variant X2
carbohydrate-responsive element-binding protein isoform X1
carbohydrate-responsive element-binding protein isoform X2
carbohydrate-responsive element-binding protein isoform X3
transducin beta like 2, transcript variant X2
transducin beta like 2, transcript variant X1
transducin beta-like protein 2 isoform X1
transducin beta-like protein 2 isoform X2
transducin beta like 2, transcript variant X3
transducin beta-like protein 2 isoform X3
BAF chromatin remodeling complex subunit BCL7B, transcript variant X1
BAF chromatin remodeling complex subunit BCL7B, transcript variant X2
BAF chromatin remodeling complex subunit BCL7B, transcript variant X3
B-cell CLL/lymphoma 7 protein family member B isoform X1
B-cell CLL/lymphoma 7 protein family member B isoform X2
B-cell CLL/lymphoma 7 protein family member B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
spermatogenesis-associated protein 16-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125336366, transcript variant X1
uncharacterized LOC125336366, transcript variant X2